- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
VENCLEXTA - - 42 (14x10mg/ 7x50mg/ 7x100mg/ 14x100mg)
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01XX52 | B | Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4 | 9176 | 54817/1 | VENCLEXTA | 42 (14x10mg/ 7x50mg/ 7x100mg/ 14x100mg) | Tablet | Oral | Interpharma S.A.L. | Abbvie Inc | USA | 190,943,809 L.L | 2.44 | E2 | Abbvie Inc | USA | 2/5/2024 | 0 |